Gene screening and prevention of hereditary breast cancer: a clinical view

被引:3
|
作者
Klijn, JGM [1 ]
Meijers-Heijboer, H
机构
[1] Dr Daniel Den Hoed Canc Ctr, Rotterdam Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands
[2] Erasmus Univ, Ctr Med, Rotterdam, Netherlands
来源
EJC SUPPLEMENTS | 2003年 / 1卷 / 01期
关键词
D O I
10.1016/S1359-6349(03)00005-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nowadays, the major tasks of the increasing number of family cancer clinics are to provide general information about cancer, to perform risk assessment, to offer (presymptomatic) DNA-testing, to advise on lifestyle, to take steps for early detection and prevention of cancer, for psychological support and to carry out research programmes by a multidisciplinary approach. In approximately 25-30%,, of the families with a hereditary pattern of breast cancer a germline mutation can be demonstrated, most commonly in the BRCA1 and BRCA2 genes. Mutations in these genes are associated with high life-time risks of breast and ovarian cancer. The introduction of MR1 increased the sensitivity for early detection of breast cancer in comparison with mammography. Thus far, prophylactic bilateral total mastectomy is the most effective and safest way of prevention but prophylactic oophorectomy and chemopreventionare reasonable alternatives. In particular young women with children make use of DNA-testing and surgical prevention. By a shared decision-making process, the patient and her medical doctor have to make the right choice of management policy based on her individual circumstances. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
  • [21] An Update on Breast Cancer Screening and Prevention
    de la Cruz, Maria Syl D.
    Sarfaty, Mona
    Wender, Richard C.
    [J]. PRIMARY CARE, 2014, 41 (02): : 283 - +
  • [22] In the Clinic Breast Cancer Screening and Prevention
    Farkas, Amy H.
    Nattinger, Ann B.
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : ITC161 - ITC176
  • [23] PREVENTION AND SCREENING FOR BREAST-CANCER
    HARPER, GR
    ENGLISBE, BH
    [J]. CANCER DETECTION AND PREVENTION, 1993, 17 (4-5): : 551 - 555
  • [24] The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review
    Toni Roeke
    Annelotte C. M. van Bommel
    Marlien P. Gaillard-Hemmink
    Henk H. Hartgrink
    Wilma E. Mesker
    Rob A. E. M. Tollenaar
    [J]. Breast Cancer Research and Treatment, 2014, 147 : 15 - 23
  • [25] Clinical outcomes in hereditary breast cancer: Implications for screening in the primary care setting.
    Schlanger, C
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (07) : 224A - 224A
  • [26] Breast Cancer Epidemiology, Prevention, and Screening
    Winters, Stella
    Martin, Charmaine
    Murphy, Daniel
    Shokar, Navkiran K.
    [J]. APPROACHES TO UNDERSTANDING BREAST CANCER, 2017, 151 : 1 - 32
  • [27] Notes on breast cancer prevention and screening
    Hans-Peter Köst
    [J]. memo - Magazine of European Medical Oncology, 2015, 8 (3) : 198 - 200
  • [28] Mutation screening of Bulgarian hereditary breast and ovarian cancer patients with multi-gene cancer panel
    Mitkova, A.
    Dodova, R.
    Pencheva, D.
    Vlahova, A.
    Taushanova-Hadjieva, M.
    Valev, S.
    Timcheva, K.
    Christova, S.
    Mitev, V.
    Kaneva, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S37 - S37
  • [29] Screening for hereditary cancer and genetic testing, epitomised by breast cancer
    Eeles, RA
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (14) : 1954 - 1962
  • [30] Physical activity and nutrition in the prevention of hereditary breast cancer
    Grill, Sabine
    Quante, Anne
    Kiechle, Marion
    [J]. GYNAKOLOGE, 2019, 52 (07): : 525 - 528